Latest news
ClearPoint Neuro (NASDAQ:CLPT) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:48:57 GMTNeuro Mind Pro Reviews 2026 - Is This the Cognitive Support Formula Buyers Have Been Searching For? - Muddy River SportsMuddy River Sports · Sat, 08 Aug 2026 04:55:52 GMTNeuro Memory Reviews 2026: Adults Determined to Stay Mentally Sharp Discover the Daily Cognitive Support Formula - Newswire.comNewswire.com · Sat, 08 Aug 2026 03:35:00 GMTNeuro Is Back Again For Another Year Of Focus And Chess - Chess.comChess.com · Thu, 06 Aug 2026 17:06:00 GMTClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.stsimplywall.st · Thu, 06 Aug 2026 11:08:58 GMTBarrow launches clinical study of ibogaine for neurological recovery - News-MedicalNews-Medical · Thu, 06 Aug 2026 04:31:00 GMTCutting-Edge Neuro-Rehabilitation Technology - Westfair CommunicationsWestfair Communications · Wed, 05 Aug 2026 12:00:00 GMTClearPoint Neuro: Regulatory Momentum Strengthens The Long-Term Investment Case (CLPT) - Seeking AlphaSeeking Alpha · Tue, 04 Aug 2026 21:10:20 GMT